Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Posted on 04/30/2026
57:18 |

Featuring perspectives from Dr Aditya Bardia and Dr Erica Mayer, including the following topics:

  • Introduction: How Selective Estrogen Receptor Degraders (SERDs) Work (0:00)
  • Second-Line Treatment for Metastatic Breast Cancer (16:01)
  • First-Line Therapy for Metastatic Disease (33:19)
  • Adjuvant Therapy (35:26)
  • Toxicity, Quality of Life (47:59)
  • New Directions (55:22)

CME information and select publications